Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term follow-on study of VIAject in type 1 diabetes mellitus
2007-006084-73Phase 3Completed
- Sponsor
- Biodel Inc.
- Start
- Mar 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of VIAject in diabetes mellitus type 1 (T1D), sponsored by Biodel Inc. Primary endpoint: Frequency of hypoglycemic events during the study. Started Mar 2009; status: completed.
02
Drugs
VIAject
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2007-006084-73.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006084-73.